Science & Research
Grapes May Support Skin Health at Genetic Level, Study Finds
A new study suggests that consuming grapes can change gene expression in human skin, supporting healthier and more resilient skin, highlighting the importance of diet in skin care.
Study Links Breast Implant Biofilms to Chronic Inflammation and BII Symptoms
A 2024 peer-reviewed study published in MDPI's Microorganisms journal identifies bacterial biofilms on breast implants as a driver of chronic inflammation and systemic symptoms associated with Breast Implant Illness (BII), offering a clinical framework for explant surgery.
Optimi Health Completes First Psilocybin Export to UK for Phase 2 Trial
Optimi Health Corp. has exported naturally derived psilocybin to the UK for a planned Phase 2 clinical trial, marking a milestone in international psychedelic drug distribution.
Microsoft Accelerates Quantum Computing Timeline, Targets Scalable System by 2029
Microsoft has moved up its goal for a practical quantum computer from 2033 to 2029, citing a breakthrough in chip performance with the Majorana 2, amid a surge of activity in the quantum computing sector.
Low Blood Pressure Shows Strongest Link to Alzheimer's Risk in New Analysis of Nearly 800,000 Adults
A new study in the Journal of the American Heart Association finds that hypotension is most strongly associated with Alzheimer's disease among several cardiovascular conditions, with stronger effects in Black and Hispanic adults, suggesting shared biological roots.
Carmed Pharmaceuticals Publishes Second Peer-Reviewed Study of Its Carvacrol-Based Formulations
Carmed Pharmaceuticals highlights a new peer-reviewed study on its formulations Vacrol® and S-Mix® in the journal Antioxidants, underscoring its commitment to scientific research as it expands into the U.S. market.
BOXABL Unveils Folding Habitat Concept for Lunar Settlements, Keeps Royalty-Free IP
BOXABL has introduced a conceptual foldable habitat called UFO for lunar and planetary settlements, separate from its Earth-focused modular housing business, and plans to offer the IP royalty-free to spur innovation.
Quantum BioPharma Completes Phase 1 Trial for Multiple Sclerosis Therapy Lucid-MS
Quantum BioPharma announces completion of Phase 1 clinical studies for Lucid-MS, a therapy targeting myelin repair in multiple sclerosis, and submission of an IND application to the FDA.
New Guideline Redefines Weight as Key Risk Factor in Cardiovascular-Kidney-Metabolic Syndrome
The first-ever clinical guideline for cardiovascular-kidney-metabolic syndrome, issued by the American Heart Association and American College of Cardiology, reframes excess weight as a primary driver of interconnected heart, kidney, and metabolic conditions, urging earlier prevention-focused conversations and coordinated care.
First-Ever Guideline on Cardiovascular-Kidney-Metabolic Syndrome Issued
The American Heart Association and the American College of Cardiology released the first clinical practice guideline on cardiovascular-kidney-metabolic (CKM) syndrome, emphasizing early screening and coordinated care to address interconnected heart, kidney, and metabolic conditions affecting nearly 90% of U.S. adults.
Trilogy Metals Launches 2026 Exploration Program at Alaska's Critical Minerals District
Trilogy Metals Inc. begins its fully funded 2026 summer exploration program at the Upper Kobuk Mineral Projects in Alaska, aiming to advance the high-grade Arctic copper project toward a construction decision.
MAX Power Mining Highlights Natural Hydrogen Progress at Global Energy Show Canada
MAX Power Mining Corp. showcases its leadership in natural hydrogen at the Global Energy Show Canada, advancing commercial evaluation at its Saskatchewan project following Canada's first subsurface natural hydrogen discovery.
Canamera Energy Metals Identifies Third Rare Earth Target at Turvolândia Project in Brazil
Canamera Energy Metals Corp. announced a third rare earth target at its Turvolândia project in Brazil, extending the exploration corridor and highlighting the potential for significant ionic clay-hosted rare earth deposits.
Aptevo and Niowave Partner to Advance Radiopharmaceutical Cancer Therapies
Aptevo Therapeutics and Niowave Inc. have formed a 50/50 strategic collaboration to develop up to three radiopharmaceutical oncology programs, combining Aptevo's targeting platforms with Niowave's isotope supply capabilities to address a $17 billion market.
BOXABL Unveils Conceptual ‘UFO’ Habitat for Lunar and Planetary Settlements
BOXABL introduced a conceptual off-world habitation system called the UFO (Unidentified Folding Object), designed to address challenges of transporting and deploying livable structures beyond Earth, with plans to make its intellectual property available royalty-free to spur innovation.
Treble Technologies and Hugging Face Launch First Open Benchmark for Far-Field ASR Models
The new Far Field ASR Leaderboard allows developers to evaluate speech recognition models under realistic acoustic conditions, addressing a key gap in voice AI performance.
Radioactive Collagen Tiles Reduce Brain Cancer Recurrence in Clinical Trial
A clinical trial found that placing radioactive collagen tiles into the brain cavity during tumor removal dramatically cuts recurrence and extends survival, offering new hope for brain cancer treatment.
Regentis Biomaterials Set to Begin European Surgeon Training for GelrinC Cartilage Implant
Regentis Biomaterials plans to commence surgeon training activities in Q3 2026 to support the commercial rollout of its CE Mark-approved GelrinC treatment for knee cartilage lesions, addressing a significant unmet need in Europe.
Quantum BioPharma Advances Multiple Sclerosis Therapy with LUCID-MS Program, Completes Phase 1 Trials
Quantum BioPharma has completed Phase 1 clinical studies for LUCID-MS, a therapy targeting myelin repair in multiple sclerosis, and filed an IND with the FDA, addressing the critical unmet need for neuroprotective treatments.
TransCode Therapeutics to Host R&D Webcast as It Advances Phase 2a Trial for Colorectal Cancer
TransCode Therapeutics will provide strategic and clinical updates during its first live R&D webcast, anchored by its Phase 2a trial of TTX-MC138 in circulating tumor DNA-positive colorectal cancer, highlighting progress in RNA-based oncology treatments.
GeoVax Study Shows Gedeptin May Enhance Checkpoint Inhibitor Responses in Resistant Tumors
Peer-reviewed research in JCI Insight demonstrates GeoVax's Gedeptin platform can sensitize resistant tumors to immune checkpoint inhibitors and activate systemic anti-tumor immunity, potentially broadening cancer immunotherapy efficacy.
Noble Mineral Exploration Launches Summer Drilling on Quebec Critical Minerals Projects
Noble Mineral Exploration Inc. begins Phase 2 surface exploration on rare earth properties in Labrador and Quebec, targeting high-grade REE mineralization critical for clean energy technologies.
Lifordi Immunotherapeutics Reports Positive Phase 1 Data for LFD-200 in Autoimmune Disease
Phase 1 data for LFD-200, a subcutaneous glucocorticoid antibody-drug conjugate, shows anti-inflammatory activity without systemic steroid toxicity, with patient dosing ongoing in rheumatoid arthritis.
HighTide Therapeutics Unveils New Data Supporting HTD1801's Renoprotective Effects at ERA 2026
New findings from HighTide Therapeutics show that its lead candidate HTD1801 protects kidney function by targeting podocyte inflammation and apoptosis, offering potential as a disease-modifying therapy for chronic kidney disease.
Redwood AI Files Patent for Chemical Optimization Technology, Aiming to Reduce R&D Costs
Redwood AI Corp. has filed a provisional patent for a technology that predicts experimental data sufficiency, potentially streamlining chemical R&D across pharmaceuticals, specialty chemicals, and defense.
Oncotelic Therapeutics Advances Nanoparticle Drug Delivery Platform to Improve Cancer Treatment Outcomes
Oncotelic Therapeutics is leveraging its Deciparticle platform and Sapu003 program to enhance drug delivery for existing cancer therapies, addressing key challenges in oncology treatment.
Microglia Protein Production Linked to Pediatric Brain Tumor Spread, Study Finds
Scientists discovered that microglia in the brain produce fibronectin proteins, enabling diffuse midline gliomas to spread, highlighting a potential therapeutic target for companies like CNS Pharmaceuticals.
Spanish Researchers Develop New Material That Could Replace Copper in EVs and Aircraft
Spanish researchers have created a chemically doped carbon nanotube fiber with 17-fold improved conductivity, potentially enabling lighter wiring in electric vehicles, drones, and aircraft.
Oncotelic Therapeutics Highlighted in BioMedWire Editorial as Drug-Delivery Market Nears $410 Billion Opportunity
Oncotelic Therapeutics (OTCQB: OTLC) was featured in a BioMedWire editorial examining the growing drug-delivery market, highlighting its Sapu003 and Deciparticle platform as nanotechnology-driven approaches to improve existing therapies.
Angkor Resources Begins Drilling at Gossan Hills and Wild Boar Prospects in Cambodia
Angkor Resources has commenced diamond drilling at its Andong Meas license in Cambodia, targeting copper at Gossan Hills and gold at Wild Boar, aiming to advance two key prospects in a single mobilization.